RNAi for Therapeutic Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNAi for Therapeutic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 siRNA
1.2.3 miRNA
1.2.4 shRNA
1.3 Market by Application
1.3.1 Global RNAi for Therapeutic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Cardiovascular
1.3.4 HBV
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global RNAi for Therapeutic Market Perspective (2017-2028)
2.2 RNAi for Therapeutic Growth Trends by Region
2.2.1 RNAi for Therapeutic Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 RNAi for Therapeutic Historic Market Size by Region (2017-2022)
2.2.3 RNAi for Therapeutic Forecasted Market Size by Region (2023-2028)
2.3 RNAi for Therapeutic Market Dynamics
2.3.1 RNAi for Therapeutic Industry Trends
2.3.2 RNAi for Therapeutic Market Drivers
2.3.3 RNAi for Therapeutic Market Challenges
2.3.4 RNAi for Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNAi for Therapeutic Players by Revenue
3.1.1 Global Top RNAi for Therapeutic Players by Revenue (2017-2022)
3.1.2 Global RNAi for Therapeutic Revenue Market Share by Players (2017-2022)
3.2 Global RNAi for Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNAi for Therapeutic Revenue
3.4 Global RNAi for Therapeutic Market Concentration Ratio
3.4.1 Global RNAi for Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNAi for Therapeutic Revenue in 2021
3.5 RNAi for Therapeutic Key Players Head office and Area Served
3.6 Key Players RNAi for Therapeutic Product Solution and Service
3.7 Date of Enter into RNAi for Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNAi for Therapeutic Breakdown Data by Type
4.1 Global RNAi for Therapeutic Historic Market Size by Type (2017-2022)
4.2 Global RNAi for Therapeutic Forecasted Market Size by Type (2023-2028)
5 RNAi for Therapeutic Breakdown Data by Application
5.1 Global RNAi for Therapeutic Historic Market Size by Application (2017-2022)
5.2 Global RNAi for Therapeutic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America RNAi for Therapeutic Market Size (2017-2028)
6.2 North America RNAi for Therapeutic Market Size by Type
6.2.1 North America RNAi for Therapeutic Market Size by Type (2017-2022)
6.2.2 North America RNAi for Therapeutic Market Size by Type (2023-2028)
6.2.3 North America RNAi for Therapeutic Market Share by Type (2017-2028)
6.3 North America RNAi for Therapeutic Market Size by Application
6.3.1 North America RNAi for Therapeutic Market Size by Application (2017-2022)
6.3.2 North America RNAi for Therapeutic Market Size by Application (2023-2028)
6.3.3 North America RNAi for Therapeutic Market Share by Application (2017-2028)
6.4 North America RNAi for Therapeutic Market Size by Country
6.4.1 North America RNAi for Therapeutic Market Size by Country (2017-2022)
6.4.2 North America RNAi for Therapeutic Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe RNAi for Therapeutic Market Size (2017-2028)
7.2 Europe RNAi for Therapeutic Market Size by Type
7.2.1 Europe RNAi for Therapeutic Market Size by Type (2017-2022)
7.2.2 Europe RNAi for Therapeutic Market Size by Type (2023-2028)
7.2.3 Europe RNAi for Therapeutic Market Share by Type (2017-2028)
7.3 Europe RNAi for Therapeutic Market Size by Application
7.3.1 Europe RNAi for Therapeutic Market Size by Application (2017-2022)
7.3.2 Europe RNAi for Therapeutic Market Size by Application (2023-2028)
7.3.3 Europe RNAi for Therapeutic Market Share by Application (2017-2028)
7.4 Europe RNAi for Therapeutic Market Size by Country
7.4.1 Europe RNAi for Therapeutic Market Size by Country (2017-2022)
7.4.2 Europe RNAi for Therapeutic Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNAi for Therapeutic Market Size (2017-2028)
8.2 Asia-Pacific RNAi for Therapeutic Market Size by Type
8.2.1 Asia-Pacific RNAi for Therapeutic Market Size by Type (2017-2022)
8.2.2 Asia-Pacific RNAi for Therapeutic Market Size by Type (2023-2028)
8.2.3 Asia-Pacific RNAi for Therapeutic Market Share by Type (2017-2028)
8.3 Asia-Pacific RNAi for Therapeutic Market Size by Application
8.3.1 Asia-Pacific RNAi for Therapeutic Market Size by Application (2017-2022)
8.3.2 Asia-Pacific RNAi for Therapeutic Market Size by Application (2023-2028)
8.3.3 Asia-Pacific RNAi for Therapeutic Market Share by Application (2017-2028)
8.4 Asia-Pacific RNAi for Therapeutic Market Size by Region
8.4.1 Asia-Pacific RNAi for Therapeutic Market Size by Region (2017-2022)
8.4.2 Asia-Pacific RNAi for Therapeutic Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America RNAi for Therapeutic Market Size (2017-2028)
9.2 Latin America RNAi for Therapeutic Market Size by Type
9.2.1 Latin America RNAi for Therapeutic Market Size by Type (2017-2022)
9.2.2 Latin America RNAi for Therapeutic Market Size by Type (2023-2028)
9.2.3 Latin America RNAi for Therapeutic Market Share by Type (2017-2028)
9.3 Latin America RNAi for Therapeutic Market Size by Application
9.3.1 Latin America RNAi for Therapeutic Market Size by Application (2017-2022)
9.3.2 Latin America RNAi for Therapeutic Market Size by Application (2023-2028)
9.3.3 Latin America RNAi for Therapeutic Market Share by Application (2017-2028)
9.4 Latin America RNAi for Therapeutic Market Size by Country
9.4.1 Latin America RNAi for Therapeutic Market Size by Country (2017-2022)
9.4.2 Latin America RNAi for Therapeutic Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNAi for Therapeutic Market Size (2017-2028)
10.2 Middle East & Africa RNAi for Therapeutic Market Size by Type
10.2.1 Middle East & Africa RNAi for Therapeutic Market Size by Type (2017-2022)
10.2.2 Middle East & Africa RNAi for Therapeutic Market Size by Type (2023-2028)
10.2.3 Middle East & Africa RNAi for Therapeutic Market Share by Type (2017-2028)
10.3 Middle East & Africa RNAi for Therapeutic Market Size by Application
10.3.1 Middle East & Africa RNAi for Therapeutic Market Size by Application (2017-2022)
10.3.2 Middle East & Africa RNAi for Therapeutic Market Size by Application (2023-2028)
10.3.3 Middle East & Africa RNAi for Therapeutic Market Share by Application (2017-2028)
10.4 Middle East & Africa RNAi for Therapeutic Market Size by Country
10.4.1 Middle East & Africa RNAi for Therapeutic Market Size by Country (2017-2022)
10.4.2 Middle East & Africa RNAi for Therapeutic Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Details
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in RNAi for Therapeutic Business (2017-2022)
11.1.5 Alnylam Pharmaceuticals Recent Developments
11.2 Arbutus Biopharma (Tekmira)
11.2.1 Arbutus Biopharma (Tekmira) Company Details
11.2.2 Arbutus Biopharma (Tekmira) Business Overview
11.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Introduction
11.2.4 Arbutus Biopharma (Tekmira) Revenue in RNAi for Therapeutic Business (2017-2022)
11.2.5 Arbutus Biopharma (Tekmira) Recent Developments
11.3 Arrowhead
11.3.1 Arrowhead Company Details
11.3.2 Arrowhead Business Overview
11.3.3 Arrowhead RNAi for Therapeutic Introduction
11.3.4 Arrowhead Revenue in RNAi for Therapeutic Business (2017-2022)
11.3.5 Arrowhead Recent Developments
11.4 Dicerna Pharmaceuticals
11.4.1 Dicerna Pharmaceuticals Company Details
11.4.2 Dicerna Pharmaceuticals Business Overview
11.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Introduction
11.4.4 Dicerna Pharmaceuticals Revenue in RNAi for Therapeutic Business (2017-2022)
11.4.5 Dicerna Pharmaceuticals Recent Developments
11.5 Mirna Therapeutics
11.5.1 Mirna Therapeutics Company Details
11.5.2 Mirna Therapeutics Business Overview
11.5.3 Mirna Therapeutics RNAi for Therapeutic Introduction
11.5.4 Mirna Therapeutics Revenue in RNAi for Therapeutic Business (2017-2022)
11.5.5 Mirna Therapeutics Recent Developments
11.6 Quark Pharmaceuticals
11.6.1 Quark Pharmaceuticals Company Details
11.6.2 Quark Pharmaceuticals Business Overview
11.6.3 Quark Pharmaceuticals RNAi for Therapeutic Introduction
11.6.4 Quark Pharmaceuticals Revenue in RNAi for Therapeutic Business (2017-2022)
11.6.5 Quark Pharmaceuticals Recent Developments
11.7 RXi Pharmaceuticals
11.7.1 RXi Pharmaceuticals Company Details
11.7.2 RXi Pharmaceuticals Business Overview
11.7.3 RXi Pharmaceuticals RNAi for Therapeutic Introduction
11.7.4 RXi Pharmaceuticals Revenue in RNAi for Therapeutic Business (2017-2022)
11.7.5 RXi Pharmaceuticals Recent Developments
11.8 Silence Therapeutics
11.8.1 Silence Therapeutics Company Details
11.8.2 Silence Therapeutics Business Overview
11.8.3 Silence Therapeutics RNAi for Therapeutic Introduction
11.8.4 Silence Therapeutics Revenue in RNAi for Therapeutic Business (2017-2022)
11.8.5 Silence Therapeutics Recent Developments
11.9 Benitec Biopharma
11.9.1 Benitec Biopharma Company Details
11.9.2 Benitec Biopharma Business Overview
11.9.3 Benitec Biopharma RNAi for Therapeutic Introduction
11.9.4 Benitec Biopharma Revenue in RNAi for Therapeutic Business (2017-2022)
11.9.5 Benitec Biopharma Recent Developments
11.10 miRagen Therapeutics
11.10.1 miRagen Therapeutics Company Details
11.10.2 miRagen Therapeutics Business Overview
11.10.3 miRagen Therapeutics RNAi for Therapeutic Introduction
11.10.4 miRagen Therapeutics Revenue in RNAi for Therapeutic Business (2017-2022)
11.10.5 miRagen Therapeutics Recent Developments
11.11 Sylentis
11.11.1 Sylentis Company Details
11.11.2 Sylentis Business Overview
11.11.3 Sylentis RNAi for Therapeutic Introduction
11.11.4 Sylentis Revenue in RNAi for Therapeutic Business (2017-2022)
11.11.5 Sylentis Recent Developments
11.12 Gradalis
11.12.1 Gradalis Company Details
11.12.2 Gradalis Business Overview
11.12.3 Gradalis RNAi for Therapeutic Introduction
11.12.4 Gradalis Revenue in RNAi for Therapeutic Business (2017-2022)
11.12.5 Gradalis Recent Developments
11.13 Sirnaomics
11.13.1 Sirnaomics Company Details
11.13.2 Sirnaomics Business Overview
11.13.3 Sirnaomics RNAi for Therapeutic Introduction
11.13.4 Sirnaomics Revenue in RNAi for Therapeutic Business (2017-2022)
11.13.5 Sirnaomics Recent Developments
11.14 Silenseed
11.14.1 Silenseed Company Details
11.14.2 Silenseed Business Overview
11.14.3 Silenseed RNAi for Therapeutic Introduction
11.14.4 Silenseed Revenue in RNAi for Therapeutic Business (2017-2022)
11.14.5 Silenseed Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global RNAi for Therapeutic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of siRNA
Table 3. Key Players of miRNA
Table 4. Key Players of shRNA
Table 5. Global RNAi for Therapeutic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global RNAi for Therapeutic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global RNAi for Therapeutic Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global RNAi for Therapeutic Market Share by Region (2017-2022)
Table 9. Global RNAi for Therapeutic Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global RNAi for Therapeutic Market Share by Region (2023-2028)
Table 11. RNAi for Therapeutic Market Trends
Table 12. RNAi for Therapeutic Market Drivers
Table 13. RNAi for Therapeutic Market Challenges
Table 14. RNAi for Therapeutic Market Restraints
Table 15. Global RNAi for Therapeutic Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global RNAi for Therapeutic Revenue Share by Players (2017-2022)
Table 17. Global Top RNAi for Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi for Therapeutic as of 2021)
Table 18. Ranking of Global Top RNAi for Therapeutic Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by RNAi for Therapeutic Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players RNAi for Therapeutic Product Solution and Service
Table 22. Date of Enter into RNAi for Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global RNAi for Therapeutic Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global RNAi for Therapeutic Revenue Market Share by Type (2017-2022)
Table 26. Global RNAi for Therapeutic Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global RNAi for Therapeutic Revenue Market Share by Type (2023-2028)
Table 28. Global RNAi for Therapeutic Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global RNAi for Therapeutic Revenue Share by Application (2017-2022)
Table 30. Global RNAi for Therapeutic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global RNAi for Therapeutic Revenue Share by Application (2023-2028)
Table 32. North America RNAi for Therapeutic Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America RNAi for Therapeutic Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America RNAi for Therapeutic Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America RNAi for Therapeutic Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America RNAi for Therapeutic Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America RNAi for Therapeutic Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe RNAi for Therapeutic Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe RNAi for Therapeutic Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe RNAi for Therapeutic Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe RNAi for Therapeutic Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe RNAi for Therapeutic Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe RNAi for Therapeutic Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific RNAi for Therapeutic Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific RNAi for Therapeutic Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific RNAi for Therapeutic Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific RNAi for Therapeutic Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific RNAi for Therapeutic Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific RNAi for Therapeutic Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America RNAi for Therapeutic Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America RNAi for Therapeutic Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America RNAi for Therapeutic Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America RNAi for Therapeutic Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America RNAi for Therapeutic Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America RNAi for Therapeutic Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa RNAi for Therapeutic Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa RNAi for Therapeutic Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa RNAi for Therapeutic Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa RNAi for Therapeutic Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa RNAi for Therapeutic Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa RNAi for Therapeutic Market Size by Country (2023-2028) & (US$ Million)
Table 62. Alnylam Pharmaceuticals Company Details
Table 63. Alnylam Pharmaceuticals Business Overview
Table 64. Alnylam Pharmaceuticals RNAi for Therapeutic Product
Table 65. Alnylam Pharmaceuticals Revenue in RNAi for Therapeutic Business (2017-2022) & (US$ Million)
Table 66. Alnylam Pharmaceuticals Recent Developments
Table 67. Arbutus Biopharma (Tekmira) Company Details
Table 68. Arbutus Biopharma (Tekmira) Business Overview
Table 69. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Product
Table 70. Arbutus Biopharma (Tekmira) Revenue in RNAi for Therapeutic Business (2017-2022) & (US$ Million)
Table 71. Arbutus Biopharma (Tekmira) Recent Developments
Table 72. Arrowhead Company Details
Table 73. Arrowhead Business Overview
Table 74. Arrowhead RNAi for Therapeutic Product
Table 75. Arrowhead Revenue in RNAi for Therapeutic Business (2017-2022) & (US$ Million)
Table 76. Arrowhead Recent Developments
Table 77. Dicerna Pharmaceuticals Company Details
Table 78. Dicerna Pharmaceuticals Business Overview
Table 79. Dicerna Pharmaceuticals RNAi for Therapeutic Product
Table 80. Dicerna Pharmaceuticals Revenue in RNAi for Therapeutic Business (2017-2022) & (US$ Million)
Table 81. Dicerna Pharmaceuticals Recent Developments
Table 82. Mirna Therapeutics Company Details
Table 83. Mirna Therapeutics Business Overview
Table 84. Mirna Therapeutics RNAi for Therapeutic Product
Table 85. Mirna Therapeutics Revenue in RNAi for Therapeutic Business (2017-2022) & (US$ Million)
Table 86. Mirna Therapeutics Recent Developments
Table 87. Quark Pharmaceuticals Company Details
Table 88. Quark Pharmaceuticals Business Overview
Table 89. Quark Pharmaceuticals RNAi for Therapeutic Product
Table 90. Quark Pharmaceuticals Revenue in RNAi for Therapeutic Business (2017-2022) & (US$ Million)
Table 91. Quark Pharmaceuticals Recent Developments
Table 92. RXi Pharmaceuticals Company Details
Table 93. RXi Pharmaceuticals Business Overview
Table 94. RXi Pharmaceuticals RNAi for Therapeutic Product
Table 95. RXi Pharmaceuticals Revenue in RNAi for Therapeutic Business (2017-2022) & (US$ Million)
Table 96. RXi Pharmaceuticals Recent Developments
Table 97. Silence Therapeutics Company Details
Table 98. Silence Therapeutics Business Overview
Table 99. Silence Therapeutics RNAi for Therapeutic Product
Table 100. Silence Therapeutics Revenue in RNAi for Therapeutic Business (2017-2022) & (US$ Million)
Table 101. Silence Therapeutics Recent Developments
Table 102. Benitec Biopharma Company Details
Table 103. Benitec Biopharma Business Overview
Table 104. Benitec Biopharma RNAi for Therapeutic Product
Table 105. Benitec Biopharma Revenue in RNAi for Therapeutic Business (2017-2022) & (US$ Million)
Table 106. Benitec Biopharma Recent Developments
Table 107. miRagen Therapeutics Company Details
Table 108. miRagen Therapeutics Business Overview
Table 109. miRagen Therapeutics RNAi for Therapeutic Product
Table 110. miRagen Therapeutics Revenue in RNAi for Therapeutic Business (2017-2022) & (US$ Million)
Table 111. miRagen Therapeutics Recent Developments
Table 112. Sylentis Company Details
Table 113. Sylentis Business Overview
Table 114. Sylentis RNAi for Therapeutic Product
Table 115. Sylentis Revenue in RNAi for Therapeutic Business (2017-2022) & (US$ Million)
Table 116. Sylentis Recent Developments
Table 117. Gradalis Company Details
Table 118. Gradalis Business Overview
Table 119. Gradalis RNAi for Therapeutic Product
Table 120. Gradalis Revenue in RNAi for Therapeutic Business (2017-2022) & (US$ Million)
Table 121. Gradalis Recent Developments
Table 122. Sirnaomics Company Details
Table 123. Sirnaomics Business Overview
Table 124. Sirnaomics RNAi for Therapeutic Product
Table 125. Sirnaomics Revenue in RNAi for Therapeutic Business (2017-2022) & (US$ Million)
Table 126. Sirnaomics Recent Developments
Table 127. Silenseed Company Details
Table 128. Silenseed Business Overview
Table 129. Silenseed RNAi for Therapeutic Product
Table 130. Silenseed Revenue in RNAi for Therapeutic Business (2017-2022) & (US$ Million)
Table 131. Silenseed Recent Developments
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNAi for Therapeutic Market Share by Type: 2021 VS 2028
Figure 2. siRNA Features
Figure 3. miRNA Features
Figure 4. shRNA Features
Figure 5. Global RNAi for Therapeutic Market Share by Application: 2021 VS 2028
Figure 6. Cancer Case Studies
Figure 7. Cardiovascular Case Studies
Figure 8. HBV Case Studies
Figure 9. Others Case Studies
Figure 10. RNAi for Therapeutic Report Years Considered
Figure 11. Global RNAi for Therapeutic Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global RNAi for Therapeutic Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global RNAi for Therapeutic Market Share by Region: 2021 VS 2028
Figure 14. Global RNAi for Therapeutic Market Share by Players in 2021
Figure 15. Global Top RNAi for Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi for Therapeutic as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by RNAi for Therapeutic Revenue in 2021
Figure 17. North America RNAi for Therapeutic Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America RNAi for Therapeutic Market Size Market Share by Type (2017-2028)
Figure 19. North America RNAi for Therapeutic Market Size Market Share by Application (2017-2028)
Figure 20. North America RNAi for Therapeutic Market Size Share by Country (2017-2028)
Figure 21. United States RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe RNAi for Therapeutic Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe RNAi for Therapeutic Market Size Market Share by Type (2017-2028)
Figure 25. Europe RNAi for Therapeutic Market Size Market Share by Application (2017-2028)
Figure 26. Europe RNAi for Therapeutic Market Size Share by Country (2017-2028)
Figure 27. Germany RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific RNAi for Therapeutic Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific RNAi for Therapeutic Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific RNAi for Therapeutic Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific RNAi for Therapeutic Market Size Share by Region (2017-2028)
Figure 37. China RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America RNAi for Therapeutic Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America RNAi for Therapeutic Market Size Market Share by Type (2017-2028)
Figure 45. Latin America RNAi for Therapeutic Market Size Market Share by Application (2017-2028)
Figure 46. Latin America RNAi for Therapeutic Market Size Share by Country (2017-2028)
Figure 47. Mexico RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa RNAi for Therapeutic Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa RNAi for Therapeutic Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa RNAi for Therapeutic Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa RNAi for Therapeutic Market Size Share by Country (2017-2028)
Figure 53. Turkey RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE RNAi for Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Alnylam Pharmaceuticals Revenue Growth Rate in RNAi for Therapeutic Business (2017-2022)
Figure 57. Arbutus Biopharma (Tekmira) Revenue Growth Rate in RNAi for Therapeutic Business (2017-2022)
Figure 58. Arrowhead Revenue Growth Rate in RNAi for Therapeutic Business (2017-2022)
Figure 59. Dicerna Pharmaceuticals Revenue Growth Rate in RNAi for Therapeutic Business (2017-2022)
Figure 60. Mirna Therapeutics Revenue Growth Rate in RNAi for Therapeutic Business (2017-2022)
Figure 61. Quark Pharmaceuticals Revenue Growth Rate in RNAi for Therapeutic Business (2017-2022)
Figure 62. RXi Pharmaceuticals Revenue Growth Rate in RNAi for Therapeutic Business (2017-2022)
Figure 63. Silence Therapeutics Revenue Growth Rate in RNAi for Therapeutic Business (2017-2022)
Figure 64. Benitec Biopharma Revenue Growth Rate in RNAi for Therapeutic Business (2017-2022)
Figure 65. miRagen Therapeutics Revenue Growth Rate in RNAi for Therapeutic Business (2017-2022)
Figure 66. Sylentis Revenue Growth Rate in RNAi for Therapeutic Business (2017-2022)
Figure 67. Gradalis Revenue Growth Rate in RNAi for Therapeutic Business (2017-2022)
Figure 68. Sirnaomics Revenue Growth Rate in RNAi for Therapeutic Business (2017-2022)
Figure 69. Silenseed Revenue Growth Rate in RNAi for Therapeutic Business (2017-2022)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Industry Market Size
